SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ASTM-AASTROM BIOSCIENCES: STEM CELL RESEARCH
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Pete who wrote (5)9/23/1997 8:29:00 PM
From: DZOO  Read Replies (1) of 1084
 
Pete: The potential cost savings associated with their product is what caught my attention. HMO's PPO's etc. are all trying to cut costs and at the same time improve patient care. ASTM's CPA appears to have hit the mark dead on. Also, I think it is fair to say that with todays volume the stock is under accumulation by some heavy hitters. I'm an active trader but I went long this one without regard to Tech Analysis or timing (which I may regret in the short run). I don't know about Morgan's $12 target but I understand there are 1 million domestic patients / year that might benefit. That would seem to be a fairly large market niche.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News